ArticleThoracic cancer2022

Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway.

Zhongshi Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.